316 related articles for article (PubMed ID: 21419447)
21. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
[TBL] [Abstract][Full Text] [Related]
22. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer].
Hayashi Y; Tawada T; Ando Y
Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752
[TBL] [Abstract][Full Text] [Related]
23. [A case of urothelial tumor involving renal pelvis, ureter and bladder in a patient receiving hemodialysis].
Kaneko Y; Takenawa J; Sasaki M
Hinyokika Kiyo; 1989 Jul; 35(7):1179-81. PubMed ID: 2801410
[TBL] [Abstract][Full Text] [Related]
24. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
Chou YH; Huang CH
Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
[TBL] [Abstract][Full Text] [Related]
25. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
Cussenot O; Davin JL
Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
[No Abstract] [Full Text] [Related]
26. Lynch Syndrome-associated Upper Tract Urothelial Carcinoma.
Wang J; Greenberg S; Yates J
Urology; 2018 Nov; 121():19-21. PubMed ID: 29958964
[No Abstract] [Full Text] [Related]
27. Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?
Krabbe LM; Lotan Y; Bagrodia A; Gayed BA; Darwish OM; Youssef RF; Bolenz C; Sagalowsky AI; Raj GV; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Apr; 191(4):926-31. PubMed ID: 24060642
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II.
Tanabe K; Nakanishi Y; Okubo N; Matsumoto S; Umino Y; Kataoka M; Yajima S; Yoshida T; Miyazaki S; Kuwata T; Ishii G; Watanabe R; Masuda H
BMC Cancer; 2023 Oct; 23(1):940. PubMed ID: 37798659
[TBL] [Abstract][Full Text] [Related]
29. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter.
Kenworthy P; Tanguay S; Dinney CP
J Urol; 1996 Feb; 155(2):501-3. PubMed ID: 8558645
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia].
Djokic M; Hadzi-Djokic J; Nikolic J; Dragicevic D; Radivojevic D
Prog Urol; 1999 Feb; 9(1):61-8. PubMed ID: 10212954
[TBL] [Abstract][Full Text] [Related]
31. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
[TBL] [Abstract][Full Text] [Related]
32. [Urothelial tumors of the upper urinary tract: epidemiologic study, diagnostic assessment, and treatment].
Begara Morillas F; Ramírez Fernández JC; Hermida Gutiérrez J; Rodríguez Molina J; Chicharro Almarza J; Blanco E; Corral Rosillo J; Luengo Alpuente S; Silmi Moyano A; Resel Estévez L
Arch Esp Urol; 1996; 49(1):27-33. PubMed ID: 8678596
[TBL] [Abstract][Full Text] [Related]
33. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
Holmäng S; Johansson SL
Cancer; 2004 Aug; 101(4):741-7. PubMed ID: 15305404
[TBL] [Abstract][Full Text] [Related]
34. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
35. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
37. Six primary cancers in one Lynch syndrome patient with chronic arsenic exposure.
Chen PC; Chen WC; Chao SC; Lin BW; Lin SC; Chen CJ; Lee JC
J Surg Oncol; 2012 Mar; 105(3):329-30. PubMed ID: 21882197
[No Abstract] [Full Text] [Related]
38. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
[TBL] [Abstract][Full Text] [Related]
39. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
Sadek S; Soloway MS; Hook S; Civantos F
J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
[TBL] [Abstract][Full Text] [Related]
40. [Review of ureteral carcinoma as seen in mapping of the cystectomized bladder].
Kim CG; Hamada H; Koh E; Saiki S; Kinouchi T; Kuroda M; Miki T; Kiyohara H; Usami M; Nakamura M
Hinyokika Kiyo; 1987 May; 33(5):692-6. PubMed ID: 3310556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
